- Guide to PHARMACOLOGY
Synonyms: A77 1726 | Aubagio® | flucyamide | HMR-1726
teriflunomide is an approved drug (FDA (2012), EMA (2013))
Compound class: Synthetic organic
Comment: Teriflunomide inhibits dihydroorotate dehydrogenase (DHODH). It is the active metabolite of leflunomide.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|No information available.
|Summary of Clinical Use
|Used to reduce flare-ups in patients with relapsing multiple sclerosis (MS).
|Mechanism Of Action and Pharmacodynamic Effects
|This is the active metabolite of leflunomide. Teriflunomide is an immunomodulatory agent that acts by inhibiting pyrimidine synthesis. A reduction in pyrimidine levels has antiproliferative and anti-inflammatory effects on T cells.
For extended ADME data see the following:
Electronic Medicines Compendium (eMC)
European Medicines Agency (EMA)